previous
     
  
next
 

The “Project focus" principle

Those who know how to pool their potential can reach even more. Following this conviction, in 2003 we decided to establish the "Project  focus" principle: In a cycle lasting for several years, Pohl-Boskamp is supporting a project dedicated to outstanding social or cultural goals, in a close cooperation. 
Such longer-term commitment fits well with our self-image. It allows the employees to see more clearly how fruitful their work can be. Conversely, the project executing organisation can do a better and reliable planning for the agreed period.

Mandacaru Foundation

Pohl-Boskamp is currently working with the Mandacaru Foundation in Brazil. It was founded by Brazilian and German doctors and residents of Vicente Pinzón II, a poor settlement in the city of Fortaleza in northeastern Brazil. The project is a model: It wants to show that the quality of life in a shanty town (favela) can only be effectively enhanced if health, educational, cultural and economic measures are taken simultaneously. The name of the Foundation is derived from a cactus that can withstand even the most drought and thus becoming a symbol of resistance in Brazil. 
But also a symbol of hope, as it announces the end of the dry season with its flower. Learn more about the objectives of the Mandacaru Foundation on its website www.mandacaru-foundation.org. We were very impressed by the commitment of this foundation. Maybe you will feel the same if you read more about it. We are more than happy to provide you with relevant information material under www.mandacaru-foundation.org.


 

 
Baldurat® – Active ingredient: dry extract of valerian root (3 - 6 : 1) [extraction agent: 70% ethanol (V/V)]. Indicated for the treatment of restlessness and disturbances in going sleep of nervous origin. For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, D-25551 Hohenlockstedt, Germany (July 2001).

Nitrolingual akut® Spray – Active ingredient: glyceryl trinitrate. Composition: 1 metered dose oromucusal spray contains 0.4 mg glyceryl trinitrate. Other ingredients: medium-chain triglycerides and partial glycerides, ethanol anhydrans, peppermint oil. Indications: prophylaxis and treatment of acute attacks of angina pectoris, acute myocardial infarction, acute left-ventricular heart failure, catheter-induced coronary spasms. Contraindications: hypersensitivity to any of the ingredients or other nitrate compounds, acute circulatory failure, cardiogenic shock, marked hypotension (syst BP < 90 mmHg), intake of phosphodiesterase inhibitors for the treatment of erectile dysfunction or pulmonary arterial hypertension. Caution in cases of hypertrophic obstructive cardiomyopathy, constrictive pericarditis, pericardial tamponade, low filling pressures (e.g. in cases of acute MI; avoid syst BP < 90 mmHg), aortic and/or mitral stenosis, orthostatic circulatory disorders, increased intracranial pressure. During pregnancy and breast-feeding, only after careful consideration whether the benefits outweigh the risks. Side effects: headache very frequent at the start of treatment, frequent hypotension with reflex tachycardia, drowsiness, dizziness and weakness. Occasional nausea, vomiting, flush, allergic skin reactions, marked decreases in blood pressure with exacerbation of angina pectoris symptoms, bradycardia with fainting. Very rare, exfoliative dermatitis. Development of tolerance and cross tolerance possible, avoid continuous high dosing. Hypoxaemia and ischaemia may occur in CHD. The ability to drive vehicles or operate machines may be impaired, especially in combination with alcohol consumption. PO. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (1).
GeloMyrtol® forte – Active ingredient: distillate of a mixture of rectified eucalyptus oil, rectified sweet orange oil, rectified myrtle oil and rectified lemon oil (66:32:1:1) (Myrtol® standardized). Indicated for acute and chronic bronchitis and inflammation of the maxillary sinuses (sinusitis). For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (01/6).
Laxopol® 1.0 g – Active ingredient: refined castor oil. For the short-term treatment of constipation. Medical advice should sought for constipation that lasts for longer than 1 week. For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (6).
GeloBronchial®-Saft – Active ingredient: liquid extract of thyme. Indications: common cold like disorders of the airways with catarrh, alleviation of symptoms of bronchitis. Warning: Ingredients include invert sugar syrup and 6.3 Vol.-% alcohol. Diabetics: sugar content of 0.75 BEU per 15 mL syrup. For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (01/11).
GeloDurat®-Salbe – Active ingredient: eucalyptus oil and levomenthol. For external use to alleviate the symptoms of  respiratory tract infections (common cold, hoarseness and uncomplicated bronchial catarrh). For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (01/5).

Nitrolingual® infus. – Active ingredient: glycerol trinitrate. Composition: 1 ml infusion solution contains 1 mg glycerol trinitrate. Other ingredients: glucose monohydrate (Ph.Eur.), 10% hydrochloric acid solution (for pH adjustment), water for injections. Indications: severe angina pectoris, acute myocardial infarction, acute left-ventricular heart failure, hypertensive crisis with acute heart failure, controlled hypotension. Contraindications: hypersensitivity to any of the ingredients or other nitrate compounds, acute circulatory failure, cardiogenic shock, toxic pulmonary oedema, marked hypotension (syst BP < 90 mmHg), disorders with increased intracranial pressure, intake of phosphodiesterase inhibitors for the treatment of erectile dysfunction or pulmonary arterial hypertension. Caution in cases of hypertrophic obstructive cardiomyopathy, constrictive pericarditis, pericardial tamponade, low filling pressures (e.g. in cases of acute MI; avoid syst BP < 90 mmHg), aortic and/or mitral valve stenosis, tendency to orthostatic circulatory disorders, severe liver or kidney disturbances. During pregnancy and breast-feeding, only if prescribed by a physician. Side effects: headache very frequent at the start of treatment; hypotension with reflex tachycardia may occur. Occasional nausea, vomiting, flush, allergic skin reactions, marked decreases in blood pressure with exacerbation of angina pectoris symptoms, bradycardia with fainting and synopses. Very rare, exfoliative dermatitis. Development of tolerance and cross tolerance possible, avoid continuous high dosing. Hypoxaemia and ischaemia may occur in CHD. The ability to drive vehicles or operate machines may be impaired, especially in combination with alcohol consumption. PO. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (July 2008).
GeloVital® Lebertrankapseln – 0.5 g/1.0 g – Active ingredient: Codliveroil for general strengthening and invigoration. For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (01/5/2).

GeloNasal®- 0.05%/-Spray 0.10% – Active ingredient: xylometazoline hydrochloride. Indications: for local application in  the nose. Contains the alpha-sympathomimetic xylometazoline. This substance narrows the blood vessels thereby reducing swelling of the mucous membrane. GeloNasal®-Tropfen 0.05%: for children between 2 and 6 years; GeloNasal®-Spray 0.10%: for schoolchildren older than 6 years and adults. For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (01/13/13).
Gelo®-Bronchialtee 400 – Active ingredients: dry extract of thyme (6.0 – 10.0:1) [70% (V/V) ethanol] and ivy leaves (4.0 – 7.5:1) [30% (V/V) ethanol]. Indications: common cold and upper respiratory tract infections (catarrh), alleviation of symptoms of bronchitis. For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt (01/01).